Details Basic Details Date Sunday, September 20, 2020 Type Presentation Materials Incidence of Cutaneous Small Vessel Vasculitis associated with Oral Anticoagulant Use Additional Information Information Host 36th International Conference on Pharmacoepidemiology & Therapeutic Risk Management Related Assessment(s) Sentinel Drug Study: Eliquis (Apixaban), Pradaxa (Dabigatran), and Xarelto (Rivaroxaban) & Cutaneous Small-Vessel Vasculitis Sentinel Drug Analysis: Cutaneous Small-Vessel Vasculitis following Direct Oral Anticoagulants (DOACs), Warfarin, or Allopurinol Use in Patients with Atrial Fibrillation: A Descriptive Analysis 36th International Conference on Pharmacoepidemiology and Therapeutic Risk Management ICPE All Access Conference Abstracts Contributors Presenter(s) Adebola Ajao, Oren Shapira, Efe Eworuke, Mohamed Mohamoud, Rongmei Zhang, Joy Kolonoski, John Connolly